Author/Editor
Ray Blanco
Publisher
Agora Financial
Description
Focuses on companies with hot new technologies, including biotech and technology stocks. Formerly run by Patrick Cox, who moved on to launch Transformational Technology Alert, a similar letter for Mauldin Economics, and Stephen Petranek and Gerald Celente have also briefly helmed this letter.
Overall Rating
Rating: 2.5/5. From 20 votes.
Please wait...
2.5
Rating from 77 votes
If you’ve subscribed to Breakthrough Technology Alert, please click the stars below to indicate your rating for this newsletter, and please share any other feedback about your experience using the comment box below.
Investment Performance
Rating from 22 votes
Rating: 2.4/5. From 22 votes.
Please wait...
Your vote
- 5 Stars 3 Votes
- 4 Stars 2 Votes
- 3 Stars 3 Votes
- 2 Stars 6 Votes
- 1 Stars 8 Votes
Quality Of Writing/Analysis
Rating from 17 votes
Rating: 2.6/5. From 17 votes.
Please wait...
Your vote
- 5 Stars 2 Votes
- 4 Stars 3 Votes
- 3 Stars 3 Votes
- 2 Stars 5 Votes
- 1 Stars 4 Votes
Value For Price
Rating from 18 votes
Rating: 2.3/5. From 18 votes.
Please wait...
Your vote
- 5 Stars 4 Votes
- 4 Stars 0 Votes
- 3 Stars 2 Votes
- 2 Stars 3 Votes
- 1 Stars 9 Votes
Customer Service
Rating from 20 votes
Rating: 2.5/5. From 20 votes.
Please wait...
Your vote
- 5 Stars 2 Votes
- 4 Stars 1 Votes
- 3 Stars 5 Votes
- 2 Stars 9 Votes
- 1 Stars 3 Votes
Been a subscriber for about 6 months now. I don’t buy the whole portfolio, but use it was a winnoning procoss. Also I use technical analysis for help with market timing. Most of these stocks are pretty volatile, wait for a good dip.
Of course since they stocks ARE volatile, you should be making sure to diversfy a bit, and only be investing a reasonable amount of your portfolio. And be prepared for the long hall. Really if just one of these picks turns out to be the next big thing, it will be pay any loosers.
Also, I actually increased my ISCO after the sell call. I’m ok with him not covering it, I will just have to follow it on my own.
Remember at the end of the day, all investment decisions are yours. They should NOT be taken blindly by following anyone.
Matthew got it dead on. Breakthrough Technology is an invaluable research service that brings many opportunities I would not otherwise know about to my attention with a fairly concise report on each recommendation. Over time, Ray has improved in regard to his sell recommendations, but there are too many stocks in his usual portfolio to fit the average investor’s portfolio allocation to this class of stocks so you must choose which to invest in for yourself.
I am not submitting a review as I am not a subscriber, not fair to judge what I have no knowledge about. Just wanted to mention that an Agora add for “TECHNOLOGY PROFITS CONFIDENTIAL” arrived today. The lengthly presentation sounded just like the “BTA” letter described by the Gumshoe reviewers. Priced at $49/ year or $89 for two years, I am wondering if this is the economy version of the of “BTA” letter? Once you subscribe will offers of more expensive publications flow into your E-mail?
I have been a reader for nearly two years and think it is the best newsletter I get. Investors need to understand that these are high risk picks but based on what appears to be really good analysis. They are buy and forget shares but I look at them most days and am usually happy. I am top heavy now in my two favourites BioTime and ISCO but believe so strongly in this technology that I will just let them ride. I do believe that Patrick is honest (and he had told us earlier that he was advising ISCO) so I was not surprised at and ignored the sell notice. He made it cear that it was a very reluctant sell and he still loved the company. So long as you understand that you only invest what you can afford to lose and are VERY patient I think that one or more will hit the jackpot.
This report has, for many persons, interesting and perhaps valuable articles. My COMPLAINT is that after reading a complete issue the info was not of value to me. Three times, over 30 days, I have sent messages that I am not satisfied and that I want to cancel for full refund. So far no acknowledgement, no credit card credit, and a new issue has just been received by e-mail (I rejected it without reading it). Potential subscribers should be made aware that cancel and refund appears to be outside their policy and such is not mentioned in their solicitations. BT is a tiny part of a large and reputable internet investment info organization and BTs silence hurts the entire org.
I have subscribed but chose not to review, despite being offered very low renewal prices. Forget making money on their recommendations, its not going to happen as most of the companies struggle to survive and, if they do get lucky, sell out so that any gain is limited. In my darker moments, I wonder whether this is anything more than a boiler shop operation.
The letter was at times interesting but the service was delivered in a way that made it difficult to follow. This is clearly an investment letter that you need to do a lot of your own research on and monitor positions very closely. The other problem is the customer service – these guys indicate that you selected automatic annual renewal – even though you didn’t – who in their right mind would. Then when you try to cancel – well goodluck – they waste your time with BS.
His selections perform much worse than the biotech index – he is comnpletely useless.
I subscribed two years ago. Since then I have bought two picks — BoiTime and International Stem Cell Corp. Both are underwater since I bought them. Although Cox’s analyses are informative, they are over long and over confident. He encourages subscribers to take a long-term view of small companies that may or may not break through. This approach will be familiar to many investors whose fingers have been burned by financial “experts”.
The question that investors should put to all such advisors is this: if your picks are so good, why do you still need my subscription money ?
I just dropped BTA after two years. It is very entertaining and educational. Each stock’s story sounds wonderful. Patrick never sells the stocks or puts in a stop loss. I picked the right stocks the first year and made money. But I held on to Patrick’s biggest winner as it was cut in half. Some of the stocks have 90% losses if you held on from the start. Fortunately I never bought those, but I had plenty of others that cost me. The science sounds great, but most of the stocks are down right now.
I don’t know what the fuss is from these “unsatisfied” subscribers, no one gets them all right. The best you can expect is that the winners are big and the losers small I have subscribed for 2 years and am very satisfied. When I was younger I used to finance several small companies like these and you must be patient. Short attacks are no problem if the company is real and develops it’s product. Markets in stocks like this are volatile by nature and in a down period even more so, but they come back quickly as well. Patrick does a great job of explaining what would otherwise put me to sleep. I am ahead on some like BTIM and waiting patiently for others to pop. I don’t watch them day to day, it’s not realistic.
Terrible track record. Bought this service about two years ago. I bought about twenty of their recommendations and with the exception of one they all turned out to be big losers.
A good deal of money could be made with this newsletter by waiting for the short pop in price after each recommendation and then shorting the stock, using a 50% stop loss. You would have stopped out on Biotime and made money on just about every other recommendation. Patrick Cox seems to pay no attention to the financial condition of the companies he recommends. If they have nifty technology, or seem about to develop nifty technology, he recommends them. There was one semiconductor company he recommended that kept going down, down, down, and Pat couldn’t seem to understand why. Well, it was because it was running out of money, that’s why. It went bankrupt. Another recommendation, ISCO, would have been a great short. That’s a stock that seems absolutely incapable of finding a bottom. It’s current at less than 25% of its recommended price. If you must take a fling on these picks wait until the price is 50% or less of what it was the day the stock was recommended before you buy.
What is the company Canadian mining company that just bought a mine in Alaska that produces minieral that can be used to create what they call the mirical material
Stansberry & Associatesinvestments is toughting a small mining company from Canada that has recently purchased a mine in Alaska, that is suppose to produce a type of mineral that can be used in making what they call the mirical material, An yone know what this mining companies name is.
China controls most of the worlds supply of this materal creating an almost monopoly.
Re Tim 8/24/12 The S & A company that they are again “recommending” is likely Northern Graphite Company ( NGPHF) we got sucked in @ 2.50 –now @ $1.00 L
Breakthrough Technology Alert: why would anyone send in $2000 and wait to receive a rebate of $1200 from Patrick Cox?
Now hyping anti-aging. Thank goodness for the Stock Gumshoe!
Breakthrough Technology is a boom or bust newsletter that is made of hype and story. And it’s fascinating. Cox says straight out that many of these picks will go to zero, but the ones that don’t will go up hundreds or thousands of percent. His more heavily hyped ones (BTX, STSI, NNVC) haven’t lit the world on fire, at least consistently, but they are still out there with worlds of potential. As well, he hasn’t closed out a stock for a loss, which may be an alarming figure given that some of them are down 90%, and those he has closed are up minimum 100%. If you have money to burn for potential homeruns and a blind fold to wear for the market’s gyrations on a $50M cap stock, then it’s an interesting, and possibly worthwhile, letter.
Read for interesting ideas/stocks, but don’t invest in them!
Crap track record and to expensive for the gains.